MarketReportsOnline.com adds “Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2015 Edition” to its library.
This report offers a comprehensive analysis of the global TAVR market, along with an in-depth study of the TAVR procedures and the regional markets of the US, Europe and Japan. The global TAVR market is dominated by two major players, Edwards Lifesciences and Medtronic which operate in a highly dynamic environment working in the direction of tapping maximum market share. Both the companies in addition to St. Jude Medical have been profiled in the present report highlighting their key financials and business strategies for growth.
Transcatheter aortic valve replacement (TAVR) Market is a relatively new technology in the field of medical science. It is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic stenosis). It is sometimes also called transcatheter aortic valve implantation (TAVI). Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery. As a result, the market of heart valve surgical procedures is witnessing a continuous decline as more and more patients requiring valve replacement are at risk for a surgical treatment. This shortcoming of the traditional surgical method has paved way for the popularity and adoption of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market for TAVR is regarded to be promising with immense growth opportunities and unmet demand to cater to.
The key factors which are anticipated to drive market growth include ageing population, healthcare expenditure, increasing obese population and gross domestic product apart from increasing prevalence of inoperable aortic stenosis. Some of the noteworthy developments of this industry include advancement in technologies and favorable reimbursement in Europe. However, the industry remains threatened by certain challenges which include regulatory issues, associated high risk and high cost of TAVR devices.
Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=398504.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables affecting this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Major points from Table of contents (http://www.marketreportsonline.com/398504-toc.html) are listed below:
1. Market Overview
2. TAVR Market Analysis
3. Market Dynamics
4. Competitive Landscape
5. Company Profiles
6. Market OutlookList of Tables
TAVR Competitive Landscape
Global TAVR Market – Total Implants by Company (2011-2014E)
The US TAVR Market – Total Implants by Company (2011-2014E)
OUS TAVR Market – Total Implants by Company (2011-2014E)
Dependent & Independent Variables (2009– 2013)
Model Summary – Coefficient of Determination
Regression Coefficients Output
List of charts
Other Related Reports on Medical Devices Market:Global Glucose Monitoring Market Report: 2015 Edition (http://www.marketreportsonline.com/398134.html) Blood Glucose Monitoring refers to the way of testing the concentration of glucose in the blood (glycemia). Monitoring blood sugar levels is an essential part of diabetes care, as waiting for symptoms of extremely high or low blood sugar levels can result in life threatening situations.
Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19) (http://www.marketreportsonline.com/394315.html) Combined Hormonal Contraceptives (CHC) is widely being used as an effective and reversible birth control method. Mainly used for preventing pregnancies but sometimes also used for treating acne vulgaris, endometriosis, polycystic ovarian syndrome and irregular menstrual flow, CHC works by preventing ovulation i.e. release of egg from ovaries. The hormones are provided in the combined pill, patch or ring.Blood Coagulation Analyzer - Product Analysis (http://www.marketreportsonline.com/395379.html) This report provides a comprehensive assessment of the blood coagulation products of the companies. It examines the latest available and emerging coagulation tests and products being utilized by the coagulation testing field and describes the current product lines of almost all of the companies known to be marketing and manufacturing instruments for blood coagulation testing.
Chinese Special Examination and Approval Procedures for Innovative Medical Devices: speed up overseas innovative medical devices entry into Chinese market (http://www.marketreportsonline.com/396455.html) Chinese regulatory authorities China Food and Drug Administration unprecedentedly set a special examination and approval procedures for innovative medical devices since March 1, 2014, which provides a opportunity to speed up overseas innovative medical devices entry into Chinese market, and reduce risk from the registration examination uncertainty and approval delays to eat up your time and energy.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441